Table 4 Effect of CurNPs and ZnONPs administration on serum liver function enzymes (ALT, AST, and GGT levels) of STZ-induced diabetic and control rats.
Groups | ALT (U/L) | AST (U/L) | GGT (U/L) |
|---|---|---|---|
Control | 32.60 ± 0.93d | 32.00 ± 0.71f. | 11.00 ± 0.71d |
HFD/STZ | 212.60 ± 0.93a | 243.61 ± 1.21a | 52.20 ± 0.86a |
HFD/STZ-Cur | 61.40 ± 0.93b | 53.60 ± 1.03d | 20.80 ± 0.58b,c |
HFD/STZ-CurNPs-10 | 31.80 ± 0.58d | 42.40 ± 0.93e | 20.60 ± 0.51b,c |
HFD/STZ-CurNPs-50 | 32.40 ± 0.93d | 40.00 ± 0.71e | 19.80 ± 0.37c |
HFD/STZ- ZnSO4 | 57.00 ± 1.41b | 72.60 ± 0.93c | 23.00 ± 1.00b |
HFD/STZ-ZnONPs-10 | 32.00 ± 0.71d | 36.00 ± 0.71f. | 23.00 ± 0.71b |
HFD/STZ-ZnONPs-50 | 36.40 ± 1.36c | 37.00 ± 0.71f. | 21.00 ± 0.71b |
HFD/STZ-MT | 31.00 ± 0.71d | 87.80 ± 0.86b | 19.60 ± 0.51c |